#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crohn's disease Extranodal marginal zone B-cell lymphoma (MALT type) Liposarcoma metastatic Squamous cell carcinoma of head and neck Richter's syndrome Glomerulonephritis rapidly progressive Angelman's syndrome Primary biliary cholangitis Philadelphia positive acute lymphocytic leukaemia Rhabdomyosarcoma Metastatic malignant melanoma Amyloidosis Ocular lymphoma Narcolepsy Burkitt's lymphoma refractory More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Basic Information Acute respiratory distress syndrome – Treatment Short-bowel syndrome – Trials in Disease Hereditary optic atrophy Andersen-Tawil syndrome Advanced systemic mastocytosis – Trials in Disease Metachromatic leukodystrophy – Life with Disease Rhabdomyosarcoma recurrent – Life with Disease Angiosarcoma metastatic – Diagnostics Hypereosinophilic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atropine Sulfate Hydralazine Hydrochloride Trientine Dihydrochloride Isotretinoin Fulvestrant [18F]-Altanserin Lib-01 Monohydrate Alfacalcidol Heparin Calcium L-Lysine Hydrochloride Povidone Granisetron Pemetrexed Diacid Monohydrate Enoxaparin Sodium Radiprodil Fludrocortisone Acetate Futibatinib RO7795081 Mebendazole Dcc-3116 More therapies…

    Learn about Your Condition

    Asplenia Endometrial cancer recurrent Adenocarcinoma Breast neoplasm Respiratory failure Adrenogenital syndrome Pyoderma gangrenosum Colorectal adenocarcinoma Oropharyngeal cancer recurrent Stem cell transplant Anal cancer stage III Hypothyroidism Endometrial cancer metastatic Aplastic anaemia Niemann-Pick disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis

    Not recruiting

    2 1
    Investigated Drugs:
    • Lutikizumab
    Czechia Germany Hungary Poland Slovakia Spain

  • Study of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis

    Not recruiting

    2 1
    Investigated Drugs:
    • Liraglutide
    Denmark France Poland Spain

  • Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Durvalumab
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium France Germany The Netherlands Poland +1

  • Study on the Effects of Metoprolol in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Metoprolol Tartrate
    Spain

  • Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Remibrutinib
    • SALICYLIC ACID
    Bulgaria Denmark Germany Greece Italy Poland +3

  • Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone
    • BMS-986365
    • Docetaxel
    Austria Czechia Denmark France Germany Ireland +6

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Jnj-77242113
    • Ustekinumab
    Bulgaria Czechia Denmark Germany Hungary Poland +1

  • Study on the Safety and Effectiveness of Subcutaneous Immunotherapy with Der p 1, Der p 2, and Der p 23 Allergens for Patients with Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Conjunctivitis
    • Conjunctivitis allergic
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus
    Spain

  • Study on the Effects of LNA043 for Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lna043
    Czechia Denmark Estonia Poland Spain
Previous Page
1 … 12 13 14 15 16 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!